We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00572377
Recruitment Status : Terminated (The investigator at Cedars stopped this study due to problems collecting payment from the sponsor.)
First Posted : December 13, 2007
Last Update Posted : June 20, 2008
Information provided by:
Cedars-Sinai Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : March 2008
  Study Completion Date : March 2008